Neo Nisidina (Paracetamol, Acetylsalicylic Acid, Caffeine)

Paracetamol, Acetylsalicylic Acid and Caffeine, the active ingredients in Neo Nisidina, are analgesic and antipyretic agents presented as an oral dosage form for oral use. They provide relief of mild to moderate pain, headache and fever in adults and children.

GNH USA supplies Neo Nisidina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑controlled manufacturing and reliable distribution. The company adheres to stringent regulatory standards and provides comprehensive logistics support for global markets, with appropriate documentation and temperature control where required.

Neo Nisidina combines three agents that act on pain and fever pathways, offering symptomatic relief for common conditions such as headache, fever, and various types of mild to moderate pain. It is suitable for adult and adolescent use. - Headache: reduces pain intensity and associated discomfort. - Fever: lowers elevated body temperature to normal range. - Mild to moderate pain: alleviates aches such as muscular, dental or menstrual pain. - Dental pain: provides effective relief following dental procedures. - Musculoskeletal pain: eases discomfort from strains, sprains and backache.

Neo Nisidina may cause adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild stomach upset that may resolve with food. - Gastric discomfort: transient indigestion or heartburn. - Insomnia: difficulty falling or staying asleep due to caffeine. - Headache: paradoxical headache in some individuals. - Increased heart rate: mild palpitations.

Serious or Rare Side Effects: - Gastrointestinal bleeding: serious bleeding in stomach or intestines. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Liver toxicity: elevated liver enzymes or hepatitis with excessive paracetamol. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Thrombocytopenia: low platelet count leading to bruising.

When using Neo Nisidina, consider the following precautions to minimize risks. - Assess liver function: avoid in patients with severe hepatic impairment. - Check aspirin allergy: contraindicated in individuals with known hypersensitivity to acetylsalicylic acid. - Avoid in children with viral infections: risk of Reye's syndrome with combined agents. - Limit caffeine intake: monitor for insomnia, tachycardia or anxiety. - Use with caution in pregnancy: consult a healthcare professional before use. - Store at room temperature: keep in the original container, protect from moisture and heat.

Neo Nisidina can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Alcohol: heightened risk of liver injury.

Moderate Interactions (Monitor Closely): - CYP1A2 inhibitors (e.g., fluvoxamine): may raise caffeine levels causing side effects. - Diuretics: caffeine can enhance diuretic effect leading to electrolyte imbalance. - Antihypertensive agents: caffeine may reduce blood pressure‑lowering efficacy.